Program
sunday, february 23
monday, february 24
- Major Symposium 1: Personalized Therapies Targeting Neoantigens
- Major Symposium 2: Cancer Immune Evasion
- Keynote Session 2
- Spotlight Sessions 1-2
- Major Symposium 3: Myeloid Cell Checkpoints
- Special Sessions 1-2
tuesday, february 25
- Major Symposium 4: Neoadjuvant Immunotherapy
- Major Symposium 5: CAR T Cells for Solid Tumors
- Keynote Session 3
- Spotlight Sessions 3-4
- Major Symposium 6: Inflammation and Cancer
- Special Sessions 3-4
wednesday february w6
- Keynote Session 4
- Educational Sessions 5-6
- Spotlight Sessions 5-6
- Keynote Session 5
- Major Symposium 7: New Roles of STING in Cancer Biology and Immunology
- Special Sessions 5-6
Sunday, February 23
EDUCATIONAL SESSIONS 1 AND 2
3:30-4:50 P.M.
educational session 1: detection of tumor-reactive t cells
EDUCATIONAL SESSION 2: Strategies to Overcome Manufacturing Challenges for Cell-Based Therapy
break
4:50-5:10 P.M.
EDUCATIONAL SESSIONS 3 AND 4
5:10-6:30 P.M.
EDUCATIONAL SESSION 3: Spatial Organization of Immune Cells and Treatment with Immunotherapy
EDUCATIONAL SESSION 4: T-cell Therapies: Advances and Challenges
WELCOME AND keynote SESSION 1
6:30-7:45 P.M.
- James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Additional speaker to be announced
Opening reception
7:45-9:30 P.M.
Monday, February 24
continental breakfast
7-8 A.M.
Major Symposium 1: Personalized Therapies Targeting Neoantigens
8-9:30 A.M.
break
9:30-9:50 A.M.
Major Symposium 2: Cancer Immune Evasion
9:50-11:20 A.M.
BREAK
11:20-11:40 A.M.
keynote session 2
11:40 A.M.-12:40 P.M.
- K. Christopher Garcia, Stanford University School of Medicine, Stanford, California
- Additional speaker to be announced
Lunch
12:40-2 p.m.
spotlight sessions 1 and 2
2-3:15 P.M.
spotlight SESSION 1: Endogenous Retroviruses in the Anti-Tumor Immune Response (Dark Genome)
Spotlight Session 2: T Cell Fitness, Dysfunction, and Exhaustion
break
3:15-3:35 P.M.
Major Symposium 3: Myeloid Cell Checkpoints
3:35-5:05 P.M.
break
5:05-5:25 P.M.
special SESSIONS 1 AND 2
5:25-6:25 P.M.
Special Session 1: Debate – Tumor Mutational Burden, Heterogeneity and Efficacy of Immunotherapy
Special Session 2: Forum – CAR-T vs TCE/ NKCE
Poster Session A / Exhibit Show / Reception
6:30-9:30 P.M.
Tuesday, February 25
CONTINENTAL BREAKFAST
7-8 A.M.
Major Symposium 4: Neoadjuvant Immunotherapy
8-9:30 A.M.
BREAK
9:30-9:50 A.M.
Major Symposium 5: CAR T Cells for Solid Tumors
9:50-11:20 A.M.
BREAK
11:20-11:40 A.M.
keynote session 3
11:40-12:40 A.M.
- Crystal L. Mackall, Stanford University School of Medicine, Stanford, California
- Carl H. June, University of Pennsylvania, Philadelphia, Pennsylvania
lunch
12:40-2 p.M.
spotlight SESSIONS 3 AND 4
2-3:15 P.M.
Spotlight Session 3: Tertiary Lymphoid Structures in Cancer
Spotlight Session 4: CAR-T in vivo Delivery
break
3:15-3:35 P.M.
Major Symposium 6: Inflammation and Cancer
3:35-5:05 P.M.
break
5:05-5:25 P.M.
special SESSIONS 3 AND 4
5:25-6:25 P.M.
Special Session 3: Forum – Big Funding Ventures and Venture Capital
Special Session 4: Forum – Comparing Academic Research and Industry Careers
Poster Session A / Exhibit Show / Reception
6:30-9:30 P.M.
Tuesday, February 25
continental breakfast
7-8 a.m.
Keynote Session 4
8-8:30 A.M.
education sessions 5 and 6
8:30-9:50 a.m.
Educational Session 5: Multi-specific Antibodies and Antibody Fusion Proteins
Educational Session 6: Immune-related Adverse Events in IO Therapy
break
9:50-10:10-a.m.
spotlight sessions 5 and 6
10:10-11:25 a.m.
Spotlight Session 5: Microbiome
Spotlight Session 6: Oncolytic Viruses and Intratumoral Immunotherapies
keynote session 5
11:45 a.m.-12:45 p.m.
- Jessica Stark, Massachusetts Institute of Technology, Cambridge, MA
- Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, Buenos Aires, Argentina